(Q72527420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6123327%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Selective actions of aspirin- and sulphasalazine-like drugs against prostaglandin synthesis and breakdown (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6123327%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

9 August 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

9 August 2023

author name string

P. K. Moore

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6123327

9 August 2023

J. R. Hoult

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6123327

9 August 2023

language of work or name

English

0 references

publication date

1 March 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6123327%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

15 March 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6123327

full work available at URL

9 August 2023

https://api.elsevier.com/content/article/PII:000629528290329X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

https://api.elsevier.com/content/article/PII:000629528290329X?httpAccept=text/plain

9 August 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

9 August 2023

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6123327%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6123327%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

969-971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6123327%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6123327%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

27 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Acetylation of prostaglandin synthetase by aspirin. Purification and properties of the acetylated protein from sheep vesicular gland

9 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

15-Hydroxyprostaglandin dehydrogenase. A review

9 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Inhibitors of prostaglandin catabolism. I. Differential sensitivity of 9-PGDH, 13-PGR and 15-PGDH to low concentrations of indomethacin

9 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Inhibition by indomethacin and aspirin of 15-hydroxyprostaglandin dehydrogenase in vitro.

9 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle

9 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Sulphasalazine analogue Ph CH 44A: Powerful and selective inhibitor of prostaglandin breakdown in vitro and in vivo

9 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis

9 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Effect of carbenoxolone on prostaglandin synthesis and degradation

9 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Distribution of four prostaglandin-metabolising enzymes in organs of the rabbit

9 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Pathways of prostaglandin F2alpha metabolism in mammalian kidneys

9 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Drug therapy: Sulfasalazine

9 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Salicylates and gastrointestinal bleeding. Acetylsalicylic acid and aspirin derivatives

9 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts).

9 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Cytoprotection by prostaglandins in rats

9 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

Gastrointestinal cytoprotection by prostaglandins

9 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0006-2952(82)90329-X

9 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6123327%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference